| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
4e-07 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |